Recombinant human erythropoietin reduces free erythrocyte protoporphyrin levels in patients on chronic dialysis

V. Piazza, G. Villa, F. Galli, S. Segagni, G. Bovio, F. Poggio, L. Picardi, A. Salvadeo

Research output: Contribution to journalArticle

Abstract

We studied the significance of free erythrocyte protoporphyrin (FEP) in relation to iron status, aluminium levels and anemia in uremic patients on chronic dialysis. All but 1 patient showed high FEP values closely related to the degree of anemia. Increased FEP levels are due to a defective heme synthesis, not related to iron deficiency or aluminium overload. Treatment of anemia with recombinant human erythropoietin reduced FEP values. We therefore hypothesize that recombinant human erythropoietin ameliorates an enzymatic defect in heme synthesis.

Original languageEnglish
Pages (from-to)54-57
Number of pages4
JournalNephron
Volume61
Issue number1
Publication statusPublished - 1992

Fingerprint

Erythropoietin
Dialysis
Erythrocytes
Anemia
Aluminum
Heme
Iron
protoporphyrin IX
Therapeutics

Keywords

  • Erythropoietin
  • Heme
  • Hemodialysis
  • Porphyrins

ASJC Scopus subject areas

  • Nephrology

Cite this

Piazza, V., Villa, G., Galli, F., Segagni, S., Bovio, G., Poggio, F., ... Salvadeo, A. (1992). Recombinant human erythropoietin reduces free erythrocyte protoporphyrin levels in patients on chronic dialysis. Nephron, 61(1), 54-57.

Recombinant human erythropoietin reduces free erythrocyte protoporphyrin levels in patients on chronic dialysis. / Piazza, V.; Villa, G.; Galli, F.; Segagni, S.; Bovio, G.; Poggio, F.; Picardi, L.; Salvadeo, A.

In: Nephron, Vol. 61, No. 1, 1992, p. 54-57.

Research output: Contribution to journalArticle

Piazza, V, Villa, G, Galli, F, Segagni, S, Bovio, G, Poggio, F, Picardi, L & Salvadeo, A 1992, 'Recombinant human erythropoietin reduces free erythrocyte protoporphyrin levels in patients on chronic dialysis', Nephron, vol. 61, no. 1, pp. 54-57.
Piazza V, Villa G, Galli F, Segagni S, Bovio G, Poggio F et al. Recombinant human erythropoietin reduces free erythrocyte protoporphyrin levels in patients on chronic dialysis. Nephron. 1992;61(1):54-57.
Piazza, V. ; Villa, G. ; Galli, F. ; Segagni, S. ; Bovio, G. ; Poggio, F. ; Picardi, L. ; Salvadeo, A. / Recombinant human erythropoietin reduces free erythrocyte protoporphyrin levels in patients on chronic dialysis. In: Nephron. 1992 ; Vol. 61, No. 1. pp. 54-57.
@article{2a3e82ffb72c49468e7a0ce40d1895c5,
title = "Recombinant human erythropoietin reduces free erythrocyte protoporphyrin levels in patients on chronic dialysis",
abstract = "We studied the significance of free erythrocyte protoporphyrin (FEP) in relation to iron status, aluminium levels and anemia in uremic patients on chronic dialysis. All but 1 patient showed high FEP values closely related to the degree of anemia. Increased FEP levels are due to a defective heme synthesis, not related to iron deficiency or aluminium overload. Treatment of anemia with recombinant human erythropoietin reduced FEP values. We therefore hypothesize that recombinant human erythropoietin ameliorates an enzymatic defect in heme synthesis.",
keywords = "Erythropoietin, Heme, Hemodialysis, Porphyrins",
author = "V. Piazza and G. Villa and F. Galli and S. Segagni and G. Bovio and F. Poggio and L. Picardi and A. Salvadeo",
year = "1992",
language = "English",
volume = "61",
pages = "54--57",
journal = "Experimental Nephrology",
issn = "0028-2766",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Recombinant human erythropoietin reduces free erythrocyte protoporphyrin levels in patients on chronic dialysis

AU - Piazza, V.

AU - Villa, G.

AU - Galli, F.

AU - Segagni, S.

AU - Bovio, G.

AU - Poggio, F.

AU - Picardi, L.

AU - Salvadeo, A.

PY - 1992

Y1 - 1992

N2 - We studied the significance of free erythrocyte protoporphyrin (FEP) in relation to iron status, aluminium levels and anemia in uremic patients on chronic dialysis. All but 1 patient showed high FEP values closely related to the degree of anemia. Increased FEP levels are due to a defective heme synthesis, not related to iron deficiency or aluminium overload. Treatment of anemia with recombinant human erythropoietin reduced FEP values. We therefore hypothesize that recombinant human erythropoietin ameliorates an enzymatic defect in heme synthesis.

AB - We studied the significance of free erythrocyte protoporphyrin (FEP) in relation to iron status, aluminium levels and anemia in uremic patients on chronic dialysis. All but 1 patient showed high FEP values closely related to the degree of anemia. Increased FEP levels are due to a defective heme synthesis, not related to iron deficiency or aluminium overload. Treatment of anemia with recombinant human erythropoietin reduced FEP values. We therefore hypothesize that recombinant human erythropoietin ameliorates an enzymatic defect in heme synthesis.

KW - Erythropoietin

KW - Heme

KW - Hemodialysis

KW - Porphyrins

UR - http://www.scopus.com/inward/record.url?scp=0026547890&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026547890&partnerID=8YFLogxK

M3 - Article

C2 - 1528341

AN - SCOPUS:0026547890

VL - 61

SP - 54

EP - 57

JO - Experimental Nephrology

JF - Experimental Nephrology

SN - 0028-2766

IS - 1

ER -